Detecting the Neuraminidase R294K Mutation in Avian Influenza A (H7N9) Virus Using Reverse Transcription Droplet Digital PCR Method

Xiuyu Lou, Hao Yan, Lingxuan Su, Yi Sun, Xinyin Wang, Liming Gong, Yin Chen, Zhen Li, Zhongbiao Fang, Haiyan Mao, Keda Chen, Yanjun ZhangViruses 2023 · DOI

TL;DR

This paper introduces a new, highly sensitive method using Reverse Transcription Droplet Digital PCR (RT-ddPCR) to detect a specific mutation (R294K) in the H7N9 avian influenza virus. This mutation confers resistance to oseltamivir, a crucial antiviral drug, making this method vital for rapid and accurate monitoring of drug resistance in clinical settings.

What Problem Does This Paper Address?

Avian Influenza A (H7N9) is a significant public health concern, particularly due to its potential for severe illness and the emergence of drug-resistant strains. Oseltamivir is a primary treatment for H7N9 infections, but mutations in the neuraminidase (NA) gene, specifically the R294K mutation, can render the virus resistant to this drug. Existing methods for detecting such mutations, like phenotypic assays and traditional sequencing, can be time-consuming, resource-intensive, or lack the sensitivity to detect low-frequency mutations. This creates a need for a faster, more accurate, and sensitive diagnostic tool to identify drug-resistant H7N9 strains, enabling timely clinical decisions and effective disease control.

Methods

The core of this research is the development and validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) assay. This technique allows for the absolute quantification of nucleic acid molecules by partitioning a sample into thousands of tiny droplets, each acting as an individual PCR reaction.

Here's a breakdown of the key methodological aspects:

  • Primer and Probe Design: Specific primers and dual TaqMan minor groove binder (MGB) probes were designed to target both the wild-type (R294) and the mutated (294K) sequences of the H7N9 NA gene. This allows for simultaneous detection of both alleles.
  • RT-ddPCR Optimization: The annealing temperature was a critical parameter optimized to achieve optimal specificity and sensitivity. Through a series of experiments, 58.0 °C was identified as the best annealing temperature.
  • Assay Validation: The developed RT-ddPCR method was rigorously validated using:
  • Plasmid Standards: Recombinant plasmids containing either the wild-type or mutant NA gene were used to assess repeatability, sensitivity, and specificity.
  • Clinical Samples: 89 clinical H7N9 virus samples were analyzed to evaluate the assay's real-world applicability.
  • Comparison with Existing Methods: The RT-ddPCR results were compared with those from RT-qPCR (Reverse Transcription quantitative PCR) and Next-Generation Sequencing (NGS) to assess its accuracy and reliability.
  • Phenotypic Testing: Neuraminidase inhibition (NAI) tests were performed on identified resistant strains to confirm their reduced sensitivity to oseltamivir.

Datasets

  • H7N9 Virus Case Samples: Eighty-nine clinical H7N9 virus samples were provided by the Zhejiang Provincial Center for Disease Control and Prevention (ZJCDC). These samples were cultured in a BSL-3 laboratory.
  • Other Influenza Virus Strains: RNA from H1N1, H3N2, B/Victoria, B/Yamagata, H5N1, and H9N2 viruses were used for specificity testing.
  • Reference Strains: GD003 R294 (sensitive) and GD003 R294K (resistant) strains were used for NAI testing.
  • NA Gene Sequences: H7N9 NA gene sequences were obtained from NCBI and GISAID databases for primer design.

No new benchmark datasets were introduced; rather, existing clinical samples and well-characterized reference strains were utilized.

Key Insights and Ideas

  • RT-ddPCR as a Sensitive Tool for SNP Detection: The study demonstrates that RT-ddPCR is a powerful technique for accurately detecting single-nucleotide polymorphisms (SNPs) like the R294K mutation, even at low frequencies.
  • Absolute Quantification Advantage: Unlike RT-qPCR, which relies on a standard curve, RT-ddPCR provides absolute quantification. This simplifies the experimental process and improves the reliability of results, especially when dealing with low viral loads or rare mutations.
  • Clinical Relevance of R294K: The identification of two clinical samples with the R294K mutation, which were then confirmed to have significantly reduced oseltamivir sensitivity, underscores the clinical importance of this mutation and the need for rapid detection methods.
  • RT-ddPCR vs. NGS: While NGS offers broader mutation discovery capabilities, RT-ddPCR is presented as a simpler, faster, and more cost-effective method for detecting specific, known mutations like R294K, making it more suitable for routine clinical diagnostics.

Key Results

  • Method Development: A highly sensitive and specific RT-ddPCR method for detecting the R294K mutation in H7N9 virus was successfully developed and optimized.
  • Sensitivity and Specificity: The RT-ddPCR method demonstrated comparable sensitivity and specificity to RT-qPCR. Its accuracy was also found to be comparable to NGS.
  • Clinical Detection: Out of 89 clinical H7N9 samples tested, two were found to harbor the R294K mutation.
  • Drug Resistance Confirmation: The two identified R294K mutant strains showed significantly reduced sensitivity to oseltamivir in neuraminidase inhibition tests.
  • Repeatability: The assay showed good repeatability, with coefficients of variation (CV) generally below 10% for higher plasmid concentrations.
  • Detection Limit: The LOD for the RT-ddPCR method was determined to be 4.00 copies/µL for WT plasmids and 6.15 copies/µL for MT plasmids.

Limitations and Future Work

  • Specificity for Known Mutations: A key limitation acknowledged is that RT-ddPCR, by design, targets specific known mutation sites. It cannot discover novel or unknown drug-resistant mutations, unlike NGS.
  • Sample Size and Mutation Frequency: The study notes that larger sample sizes and higher mutation frequencies are generally required for more reliable results with RT-ddPCR, especially when detecting rare variants.
  • Missed Mutations: When using RT-ddPCR to target specific sites, there's a risk of missing other important or potential drug-resistant mutations in the H7N9 virus.

The authors suggest that this RT-ddPCR method is a valuable tool for quantitative detection of the R294K mutation. Future work could involve expanding the assay to detect other known drug-resistance mutations simultaneously or exploring its application in a broader range of influenza virus subtypes.

Summary updated

Abstract

The R294K mutation in neuraminidase (NA) causes resistance to oseltamivir in the avian influenza virus H7N9. Reverse transcription droplet digital polymerase chain reaction (RT-dd PCR) is a novel technique for detecting single-nucleotide polymorphisms. This study aimed to develop an RT-dd PCR method for detecting the R294K mutation in H7N9. Primers and dual probes were designed using the H7N9 NA gene and the annealing temperature was optimized at 58.0 °C. The sensitivity of our RT-dd PCR method was not significantly different from that of RT-qPCR (<i>p</i> = 0.625), but it could specifically detect R294 and 294K in H7N9. Among 89 clinical samples, 2 showed the R294K mutation. These two strains were evaluated using a neuraminidase inhibition test, which revealed that their sensitivity to oseltamivir was greatly reduced. The sensitivity and specificity of RT-dd PCR were similar to those of RT-qPCR and its accuracy was comparable to that of NGS. The RT-dd PCR method had the advantages of absolute quantitation, eliminating the need for a calibration standard curve, and being simpler in both experimental operation and result interpretation than NGS. Therefore, this RT-dd PCR method can be used to quantitatively detect the R294K mutation in H7N9.
BibTeX
@inproceedings{lou2023detecting,
  author = {Xiuyu Lou and Hao Yan and Lingxuan Su and Yi Sun and Xinyin Wang and Liming Gong and Yin Chen and Zhen Li and Zhongbiao Fang and Haiyan Mao and Keda Chen and Yanjun Zhang},
  title = {{Detecting the Neuraminidase R294K Mutation in Avian Influenza A (H7N9) Virus Using Reverse Transcription Droplet Digital PCR Method}},
  booktitle = {Viruses},
  year = {2023},
  doi = {10.3390/v15040983},
}
Figure